Preventing antiretroviral anarchy in sub-Saharan Africa
Identifieur interne : 008721 ( Main/Exploration ); précédent : 008720; suivant : 008722Preventing antiretroviral anarchy in sub-Saharan Africa
Auteurs : Ad Harries [Malawi, Niger] ; Ds Nyangulu [Malawi] ; Nj Hargreaves [Malawi, Royaume-Uni] ; O. Kaluwa ; Fm Salaniponi [Malawi]Source :
- The Lancet [ 0140-6736 ] ; 2001.
Descripteurs français
- Wicri :
- topic : Entreprise privée, Santé publique.
English descriptors
- KwdEn :
- African countries, Aids cases, Aids epidemic, Antiretroviral, Antiretroviral drug programme, Antiretroviral drugs, Antiretroviral programme, Antiretroviral therapy, Antiretroviral treatment, Antituberculosis treatment, Central unit, Correct answers, Counselling, Cumulative number, Diagnostic material, Donor support, Drug resistance, Essential package, False knowledge, Feasibility studies, Health sector reform, Highest priority, Industrialised countries, Joint programme, Lancet, Lancet publishing group, Many countries, National aids control programme, National tuberculosis control programme, National tuberculosis control programmes, National tuberculosis programme, Nationwide coverage, Opportunistic infections, Overall objective, Passive case, Pilot districts, Poor adherence, Private sector, Programme, Programme development plan, Public health, Quarterly basis, Regular supply, Seropositive patients, Subsaharan africa, Testing services, Treatment unit, Treatment units, Tuberculosis, Tuberculosis cases, Tuberculosis control, Tuberculosis control policy package, Tuberculosis control programmes, Tuberculosis programme, Tuberculosis programmes, Viral load, Voluntary counselling.
- Teeft :
- African countries, Aids cases, Aids epidemic, Antiretroviral, Antiretroviral drug programme, Antiretroviral drugs, Antiretroviral programme, Antiretroviral therapy, Antiretroviral treatment, Antituberculosis treatment, Central unit, Correct answers, Counselling, Cumulative number, Diagnostic material, Donor support, Drug resistance, Essential package, False knowledge, Feasibility studies, Health sector reform, Highest priority, Industrialised countries, Joint programme, Lancet, Lancet publishing group, Many countries, National aids control programme, National tuberculosis control programme, National tuberculosis control programmes, National tuberculosis programme, Nationwide coverage, Opportunistic infections, Overall objective, Passive case, Pilot districts, Poor adherence, Private sector, Programme, Programme development plan, Public health, Quarterly basis, Regular supply, Seropositive patients, Subsaharan africa, Testing services, Treatment unit, Treatment units, Tuberculosis, Tuberculosis cases, Tuberculosis control, Tuberculosis control policy package, Tuberculosis control programmes, Tuberculosis programme, Tuberculosis programmes, Viral load, Voluntary counselling.
Abstract
Summary: Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS in industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.1 Treatment of HIV-infection is likely to be lifelong.2 Unfortunately, many HIV-infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.
Url:
DOI: 10.1016/S0140-6736(01)05551-9
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002870
- to stream Istex, to step Curation: 002870
- to stream Istex, to step Checkpoint: 003C84
- to stream Main, to step Merge: 008890
- to stream Main, to step Curation: 008721
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Preventing antiretroviral anarchy in sub-Saharan Africa</title>
<author><name sortKey="Harries, Ad" sort="Harries, Ad" uniqKey="Harries A" first="Ad" last="Harries">Ad Harries</name>
</author>
<author><name sortKey="Nyangulu, Ds" sort="Nyangulu, Ds" uniqKey="Nyangulu D" first="Ds" last="Nyangulu">Ds Nyangulu</name>
</author>
<author><name sortKey="Hargreaves, Nj" sort="Hargreaves, Nj" uniqKey="Hargreaves N" first="Nj" last="Hargreaves">Nj Hargreaves</name>
</author>
<author><name sortKey="Kaluwa, O" sort="Kaluwa, O" uniqKey="Kaluwa O" first="O" last="Kaluwa">O. Kaluwa</name>
</author>
<author><name sortKey="Salaniponi, Fm" sort="Salaniponi, Fm" uniqKey="Salaniponi F" first="Fm" last="Salaniponi">Fm Salaniponi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7C8370638FBEEFC2C370675120AE57B13D56EDFA</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0140-6736(01)05551-9</idno>
<idno type="url">https://api.istex.fr/document/7C8370638FBEEFC2C370675120AE57B13D56EDFA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002870</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002870</idno>
<idno type="wicri:Area/Istex/Curation">002870</idno>
<idno type="wicri:Area/Istex/Checkpoint">003C84</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003C84</idno>
<idno type="wicri:doubleKey">0140-6736:2001:Harries A:preventing:antiretroviral:anarchy</idno>
<idno type="wicri:Area/Main/Merge">008890</idno>
<idno type="wicri:Area/Main/Curation">008721</idno>
<idno type="wicri:Area/Main/Exploration">008721</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Preventing antiretroviral anarchy in sub-Saharan Africa</title>
<author><name sortKey="Harries, Ad" sort="Harries, Ad" uniqKey="Harries A" first="Ad" last="Harries">Ad Harries</name>
<affiliation wicri:level="1"><country xml:lang="fr">Malawi</country>
<wicri:regionArea>National Tuberculosis Control Programme, Community Health Science Unit, Lilongwe</wicri:regionArea>
<wicri:noRegion>Lilongwe</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Malawi</country>
<wicri:regionArea>Correspondence to: Prof A D Harries, c/o British High Commission, PO Box 30042, Lilongwe 3</wicri:regionArea>
<wicri:noRegion>Lilongwe 3</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Niger</country>
</affiliation>
</author>
<author><name sortKey="Nyangulu, Ds" sort="Nyangulu, Ds" uniqKey="Nyangulu D" first="Ds" last="Nyangulu">Ds Nyangulu</name>
<affiliation wicri:level="1"><country xml:lang="fr">Malawi</country>
<wicri:regionArea>National Tuberculosis Control Programme, Community Health Science Unit, Lilongwe</wicri:regionArea>
<wicri:noRegion>Lilongwe</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hargreaves, Nj" sort="Hargreaves, Nj" uniqKey="Hargreaves N" first="Nj" last="Hargreaves">Nj Hargreaves</name>
<affiliation wicri:level="1"><country xml:lang="fr">Malawi</country>
<wicri:regionArea>National Tuberculosis Control Programme, Community Health Science Unit, Lilongwe</wicri:regionArea>
<wicri:noRegion>Lilongwe</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Liverpool School of Tropical Medicine, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kaluwa, O" sort="Kaluwa, O" uniqKey="Kaluwa O" first="O" last="Kaluwa">O. Kaluwa</name>
<affiliation><wicri:noCountry code="subField">Lilongwe</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Salaniponi, Fm" sort="Salaniponi, Fm" uniqKey="Salaniponi F" first="Fm" last="Salaniponi">Fm Salaniponi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Malawi</country>
<wicri:regionArea>National Tuberculosis Control Programme, Community Health Science Unit, Lilongwe</wicri:regionArea>
<wicri:noRegion>Lilongwe</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">358</biblScope>
<biblScope unit="issue">9279</biblScope>
<biblScope unit="page" from="410">410</biblScope>
<biblScope unit="page" to="414">414</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>African countries</term>
<term>Aids cases</term>
<term>Aids epidemic</term>
<term>Antiretroviral</term>
<term>Antiretroviral drug programme</term>
<term>Antiretroviral drugs</term>
<term>Antiretroviral programme</term>
<term>Antiretroviral therapy</term>
<term>Antiretroviral treatment</term>
<term>Antituberculosis treatment</term>
<term>Central unit</term>
<term>Correct answers</term>
<term>Counselling</term>
<term>Cumulative number</term>
<term>Diagnostic material</term>
<term>Donor support</term>
<term>Drug resistance</term>
<term>Essential package</term>
<term>False knowledge</term>
<term>Feasibility studies</term>
<term>Health sector reform</term>
<term>Highest priority</term>
<term>Industrialised countries</term>
<term>Joint programme</term>
<term>Lancet</term>
<term>Lancet publishing group</term>
<term>Many countries</term>
<term>National aids control programme</term>
<term>National tuberculosis control programme</term>
<term>National tuberculosis control programmes</term>
<term>National tuberculosis programme</term>
<term>Nationwide coverage</term>
<term>Opportunistic infections</term>
<term>Overall objective</term>
<term>Passive case</term>
<term>Pilot districts</term>
<term>Poor adherence</term>
<term>Private sector</term>
<term>Programme</term>
<term>Programme development plan</term>
<term>Public health</term>
<term>Quarterly basis</term>
<term>Regular supply</term>
<term>Seropositive patients</term>
<term>Subsaharan africa</term>
<term>Testing services</term>
<term>Treatment unit</term>
<term>Treatment units</term>
<term>Tuberculosis</term>
<term>Tuberculosis cases</term>
<term>Tuberculosis control</term>
<term>Tuberculosis control policy package</term>
<term>Tuberculosis control programmes</term>
<term>Tuberculosis programme</term>
<term>Tuberculosis programmes</term>
<term>Viral load</term>
<term>Voluntary counselling</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>African countries</term>
<term>Aids cases</term>
<term>Aids epidemic</term>
<term>Antiretroviral</term>
<term>Antiretroviral drug programme</term>
<term>Antiretroviral drugs</term>
<term>Antiretroviral programme</term>
<term>Antiretroviral therapy</term>
<term>Antiretroviral treatment</term>
<term>Antituberculosis treatment</term>
<term>Central unit</term>
<term>Correct answers</term>
<term>Counselling</term>
<term>Cumulative number</term>
<term>Diagnostic material</term>
<term>Donor support</term>
<term>Drug resistance</term>
<term>Essential package</term>
<term>False knowledge</term>
<term>Feasibility studies</term>
<term>Health sector reform</term>
<term>Highest priority</term>
<term>Industrialised countries</term>
<term>Joint programme</term>
<term>Lancet</term>
<term>Lancet publishing group</term>
<term>Many countries</term>
<term>National aids control programme</term>
<term>National tuberculosis control programme</term>
<term>National tuberculosis control programmes</term>
<term>National tuberculosis programme</term>
<term>Nationwide coverage</term>
<term>Opportunistic infections</term>
<term>Overall objective</term>
<term>Passive case</term>
<term>Pilot districts</term>
<term>Poor adherence</term>
<term>Private sector</term>
<term>Programme</term>
<term>Programme development plan</term>
<term>Public health</term>
<term>Quarterly basis</term>
<term>Regular supply</term>
<term>Seropositive patients</term>
<term>Subsaharan africa</term>
<term>Testing services</term>
<term>Treatment unit</term>
<term>Treatment units</term>
<term>Tuberculosis</term>
<term>Tuberculosis cases</term>
<term>Tuberculosis control</term>
<term>Tuberculosis control policy package</term>
<term>Tuberculosis control programmes</term>
<term>Tuberculosis programme</term>
<term>Tuberculosis programmes</term>
<term>Viral load</term>
<term>Voluntary counselling</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Entreprise privée</term>
<term>Santé publique</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">Summary: Combination antiretroviral therapy has dramatically improved the survival of patients living with HIV and AIDS in industrialised countries of the world. Despite this enormous benefit, there are some major problems and obstacles to be overcome.1 Treatment of HIV-infection is likely to be lifelong.2 Unfortunately, many HIV-infected individuals cannot tolerate the toxic effects of the drugs, or have difficulty complying with treatment which involves large numbers of pills and complicated dosing schedules. Poor adherence to treatment leads to the emergence of drug-resistant viral strains that need new combinations of drugs or new drugs altogether.</div>
</front>
</TEI>
<affiliations><list><country><li>Malawi</li>
<li>Niger</li>
<li>Royaume-Uni</li>
</country>
</list>
<tree><noCountry><name sortKey="Kaluwa, O" sort="Kaluwa, O" uniqKey="Kaluwa O" first="O" last="Kaluwa">O. Kaluwa</name>
</noCountry>
<country name="Malawi"><noRegion><name sortKey="Harries, Ad" sort="Harries, Ad" uniqKey="Harries A" first="Ad" last="Harries">Ad Harries</name>
</noRegion>
<name sortKey="Hargreaves, Nj" sort="Hargreaves, Nj" uniqKey="Hargreaves N" first="Nj" last="Hargreaves">Nj Hargreaves</name>
<name sortKey="Harries, Ad" sort="Harries, Ad" uniqKey="Harries A" first="Ad" last="Harries">Ad Harries</name>
<name sortKey="Nyangulu, Ds" sort="Nyangulu, Ds" uniqKey="Nyangulu D" first="Ds" last="Nyangulu">Ds Nyangulu</name>
<name sortKey="Salaniponi, Fm" sort="Salaniponi, Fm" uniqKey="Salaniponi F" first="Fm" last="Salaniponi">Fm Salaniponi</name>
</country>
<country name="Niger"><noRegion><name sortKey="Harries, Ad" sort="Harries, Ad" uniqKey="Harries A" first="Ad" last="Harries">Ad Harries</name>
</noRegion>
</country>
<country name="Royaume-Uni"><noRegion><name sortKey="Hargreaves, Nj" sort="Hargreaves, Nj" uniqKey="Hargreaves N" first="Nj" last="Hargreaves">Nj Hargreaves</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008721 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008721 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:7C8370638FBEEFC2C370675120AE57B13D56EDFA |texte= Preventing antiretroviral anarchy in sub-Saharan Africa }}
This area was generated with Dilib version V0.6.32. |